CMS IPPS Proposed Rule Includes Higher Paying DRG For Brain Aneurysms
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will try to persuade CMS to create a separate diagnosis related group for unruptured brain aneurysms that would correspond with a newly created DRG for ruptured brain aneurysms
You may also be interested in...
IPPS Rule Lowers FY 2005 Add-On Threshold, Denies InFuse Application
CMS' decision to lower the cost threshold for new devices to qualify for technology "add-on" payments under the IPPS assumes that the number of applications for the additional reimbursement will remain sparse
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.